Alzheimer's setback prompts rethink of Lilly, Biogen stock outlooks

NEW YORK, Nov 23 (Reuters) - Eli Lilly & Co's massive setback for its experimental Alzheimer's disease treatment on Wednesday sent investors scrambling to re-evaluate shares of the U.S. drugmaker... [Source]

Publication Date: Wednesday, 23 November 2016 at 22:30:38

Origin: reuters.com

Category: hotStocksNews

Topics: Lilly, setback, Alzheimer's, drugmaker, re-evaluate shares, scrambling, investors, disease treatment, experimental, massive, (Reuters), outlooks, stock, Biogen, rethink, prompts

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/rnP7OA0BmNI/health-alzheimers-stocks-idUSL1N1DO1CB

UPDATE 1-Ferrari races to new high after earnings top forecast

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:48:11

UPDATE 2-Ralph Lauren CEO to leave after differences with founder

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:24:14

UPDATE 1-Sterling, gilt yields skid as BoE seems in no rush to raise rates

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:03:29

UPDATE 2-Fingerprint Cards suffers fresh setback with weak outlook

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:30:03

UPDATE 3-Daimler pursues new records in tougher environment

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:27:59

Analyzed News